Introducing Keynote Speakers for the Upcoming Cytokines 2024 & KAI 2024 Joint Meeting
Annual Meeting

Introducing Keynote Speakers for the Upcoming Cytokines 2024 & KAI 2024 Joint Meeting

Dr. Judith Allen is a professor of Immunobiology at the University of Manchester. The Allen laboratory investigates the host immune response to parasite infection with a focus on type 2 immunity, the response mammals characteristically make to large multicellular parasites (helminths). Nobel Laureate Dr. Drew Weissman is a professor of Medicine at the Perelman School of Medicine, University of Pennsylvania. Dr. Weissman, in collaboration with Nobel Laureate Dr. Katalin Karikó, discovered the ability of modified nucleosides in RNA to suppress activation of innate immune sensors and increase the translation of mRNA containing certain modified nucleosides. [READ MORE]

Dr. Brian Kim on the left, and Dr. David Artis on the right at their visit in February to Allen Institute in Seattle, WA. Photo from Dr Kim’s Twitter/X account.
Members in the News

The Tango of Sensation and Inflammation Emerges

Dr. Brian Kim on the left, and Dr. David Artis on the right at their visit in February to Allen Institute in Seattle, WA. Photo from Dr Kim’s Twitter/X account.

Some dermatological disorders such as atopic dermatitis, alopecia areater, and vitiligo have few treatments available due to the lack of effective medications currently on the market. However, this might change soon with the formation of a new biotech entity called Alys Pharmaceuticals, Inc. that launched on 12th of February. It started with a substantial 100-million-dollar investment from Medicxi, the European healthcare investment fund, with the goal of transforming the treatment paradigm for several dermatology indications of significant prevalence and major unmet need. Alys, based in Boston and Geneva, is the combination of the assets and platforms of Aldena Therapeutics, Graegis Pharmaceuticals, Granular Therapeutics, Klirna Biotech, Nira Biosciences and Vimela Therapeutics, and has a world class leadership team that brings together experts across dermatology and advanced scientific fields. [READ MORE]

Mark Travis
Member Highlights

Member Highlight Interview with Mark Travis, Ph.D.

Mark Travis (Univ. of Manchester) is not an immunologist by training…. I did my BSc in Biochemistry and Genetics at Lancaster University, then a PhD in Protein Biochemistry at the University of Manchester, working on how integrins bind to ligands and signal. I then did my post-doc at UCSF, where I started working on integrins that bind and activate the cytokine TGF-beta. I made a conditional knockout mouse while I was there that got an intestinal inflammation phenotype, so I quickly morphed into becoming a mucosal immunologist…. which I have been ever since. [READ MORE]

Irini Sereti
Member Highlights

Member Highlight Interview with Irini Sereti, MD, MHS.

In both the clinic and the lab, I study inflammatory complications in people with HIV and the impact of CD4 lymphopenia in HIV and other conditions, specifically a rare disorder of unclear etiology called idiopathic CD4 lymphopenia (ICL). Lots of work on biomarkers and immune-based therapies in these conditions hence my affinity for cytokines. I currently work at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) and am the incoming chief of the Laboratories of Immunoregulation and Molecular Microbiology. [READ MORE]

2024 ICIS Young Investigator Award Nominations/Applications - Due April 3, 2024
Awards

2024 ICIS Young Investigator Award Nominations/Applications due April 3rd

Candidates may apply or be nominated for MORE THAN ONE YOUNG INVESTIGATOR AWARD using the Nomination/Application Form below as well as for a Cytokines 2024 Travel Award (applied for via the Cytokines 2024 Abstract Submission), but will not be awarded more than one award in a given year. Deadline for submitting Young Investigator award application is extended to Wednesday, 3 April, 2024.

Nominations by mentors and/or colleagues for the Young Investigator Awards or self-applicants, please use one form for each candidate for ALL 2024 Young Investigator Award nominations or applications. Candidates may be nominated for more than one award using the same form (multi-select), but please use a separate form for each candidate. [READ MORE]